Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Per 012009

<< Previous

Bullboard Posts

Next >>

Comment by Longholder99on Oct 27, 2024 7:47pm

255 Views

Post# 36284306

RE:RE:Per 012009

I wonder if the specified lack of side effects and/or quality of life reporting that we arent seeing in the clinical reports could be coming via the extra steps taken by the central lab (reaching out to patients once again) as a way of seeking verification of the surrogate endpoints required for AA approval?

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading